Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
328 Leser
Artikel bewerten:
(2)

Black Book Research: Hospitals Not Waiting for the Policy Hammer to Fall: Rapid Preparations Underway for Proposed 200% Pharmaceutical Tariffs, New Black Book Flash Survey Finds

Hospitals brace for fallout as potential $200B in drug import tariffs threaten cost stability and patient access

TAMPA, FL / ACCESS Newswire / July 9, 2025 / With the threat of sweeping 200% tariffs on pharmaceutical imports proposed by the Trump administration, U.S. hospitals are wasting no time preparing for the potential impact. According to an urgent flash survey from Black Book Research, hospital leaders are rapidly deploying mitigation strategies to address what could become one of the most disruptive cost shocks in recent healthcare history.

The independent survey, conducted within 24 hours of the proposed tariffs' announcement, gathered insight from 100 healthcare leaders - including 42 hospital administrators, 30 pharmacy department executives, and 28 materials management executives across all regions of the U.S. The results signal swift and focused action across five critical implementation fronts as hospitals seek to blunt the financial and clinical fallout of rising drug costs.

CATEGORY 1: Pharmaceutical Supply Chain and Inventory Management (Reported by 28 Materials Management Executives)
U.S. hospital supply chain leaders are moving fast to reduce foreign pharmaceutical dependency:

  • 58% are actively securing new contracts with domestic drug suppliers

  • 79% are stockpiling essential medications in anticipation of cost spikes and shortages

  • 49% report immediate readiness to expand warehousing and adjust supply workflows

CATEGORY 2: Financial Impact Modeling & Clinical Protocol Adjustments (Reported by 42 Hospital Administrators)
C-suite leaders are bracing for major budgetary shocks:

  • 16% have launched comprehensive financial modeling to assess potential cost overruns

  • 90% are preparing to switch formularies to lower-cost alternatives, including off-patent medications

  • 27% are ready to execute contingency clinical pathways

CATEGORY 3: Operational and Technological Readiness (Reported by 30 Pharmacy Executives)
Pharmacy departments are adapting rapidly:

  • 44% are revising therapeutic protocols to adapt to changing drug availability

  • 24% are investing in predictive analytics and AI-driven forecasting tools

  • 28% report immediate capability to implement changes if tariffs take effect

CATEGORY 4: Patient Communication and Engagement Plans (Reported by 42 Hospital Administrators)
Leaders are preparing to address patient concerns:

  • 18% are increasing patient counseling around medication changes and affordability concerns

  • 14% are drafting transparent communication plans to manage public reaction and trust

  • 21% report immediate capability to launch patient engagement campaigns

CATEGORY 5: Risk Management and Innovation Strategy (Reported by 30 Pharmacy Department Leaders)
Pharmacy leadership is also taking longer-term, innovation-driven action:

  • 11% are participating in policy advocacy and industry coalition efforts

  • 44% are accelerating their transitions to biosimilars and generics

  • 19% report immediate capability to activate new cost-saving formularies

Despite the urgency surrounding the proposed 200% pharmaceutical import tariffs, the Black Book flash survey reveals that many hospitals are less prepared than current headlines might suggest. While a number of institutions have initiated mitigation efforts, the majority of respondents report significant gaps in readiness, with many still in the early stages of assessing potential impacts and developing actionable strategies. This lag in preparation heightens the risk of operational disruption and cost volatility, underscoring the need for accelerated, coordinated responses across the hospital sector.

"These survey results clearly illustrate the urgency and severity of the potential impact. Leaders are not taking chances with patient access or fiscal health," said Doug Brown, Black Book Research founder.

About Black Book Research
Black Book Research is the healthcare industry's trusted source for independent, unbiased insights on IT strategy, operations, and readiness. Through advanced flash survey tools - including online panels, mobile sampling, and third-party targeting - Black Book delivers real-time intelligence when rapid changes demand instant awareness. For additional data or to explore Black Book's research capabilities, visit: www.blackbookmarketresearch.com or contact research@blackbookmarketresearch.com

Contact Information

Press Office
research@blackbookmarketresearch.com
8008637590

.

SOURCE: Black Book Research



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/hospitals-not-waiting-for-the-policy-hammer-to-fall-rapid-preparation-1047105

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.